Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model
Abstract Left atrial appendage (LAA) closure is being developed as an alternative for stroke prevention in patients with atrial fibrillation that cannot tolerate long-term oral anticoagulation. To assess the feasibility, safety, and performance of a novel modified Occlutech LAA closure device in a p...
Enregistré dans:
Auteurs principaux: | Markus Reinthaler, Johannes Grosshauser, Tanja Schmidt, Juliane Unger, Ross Morgan, Friederike Zimmermann, Johannes Hartung, Claudio Seppelt, Denitsa Meteva, Wolfram Haider, Ulf Landmesser, Carsten Skurk |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/29e4836ee08347ceb7cc73c23b07c720 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Device-Related Thrombus After Left Atrial Appendage Closure
par: Philippe Garot, et autres
Publié: (2019) -
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility
par: Swaans MJ, et autres
Publié: (2016) -
Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP
par: Michael Behnes, et autres
Publié: (2017) -
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
par: Toshiaki Isogai, et autres
Publié: (2021) -
Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
par: Mark S Slaughter, et autres
Publié: (2021)